HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cory Mavis Selected Research

MLN2238

11/2013MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cory Mavis Research Topics

Disease

16Lymphoma (Lymphomas)
11/2023 - 06/2011
12B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 12/2010
10Neoplasms (Cancer)
01/2023 - 06/2014
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2023 - 02/2016
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 06/2014
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 12/2010
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
05/2015 - 02/2012
1Residual Neoplasm
01/2022
1COVID-19
01/2021
1Type 2 Diabetes Mellitus (MODY)
01/2020
1Burkitt Lymphoma (Burkitt's Lymphoma)
04/2018
1T-Cell Lymphoma (Lymphoma, T Cell)
05/2015
1Multiple Myeloma
09/2013
1Hematologic Neoplasms (Hematological Malignancy)
12/2010

Drug/Important Bio-Agent (IBA)

18Rituximab (Mabthera)FDA Link
11/2023 - 06/2011
5Bortezomib (Velcade)FDA Link
02/2017 - 12/2010
4Proteasome InhibitorsIBA
12/2018 - 12/2010
3carfilzomibIBA
11/2023 - 09/2013
3Proteasome Endopeptidase Complex (Proteasome)IBA
11/2023 - 09/2013
3ofatumumabFDA Link
01/2022 - 02/2012
3EnzymesIBA
07/2020 - 06/2014
3CaspasesIBA
12/2018 - 11/2013
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2023 - 06/2014
2Apoptosis Regulatory ProteinsIBA
01/2023 - 09/2013
2Proteins (Proteins, Gene)FDA Link
12/2020 - 12/2010
2pevonedistatIBA
07/2020 - 03/2016
2Enzyme Inhibitors (Inhibitors, Enzyme)IBA
07/2020 - 03/2016
2Histone Deacetylases (Histone Deacetylase)IBA
02/2016 - 05/2015
2Histone Deacetylase InhibitorsIBA
02/2016 - 05/2015
1Prednisone (Sone)FDA LinkGeneric
11/2023
1UbiquitinIBA
11/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2023
1Vincristine (Oncovin)FDA LinkGeneric
11/2023
1tapotoclaxIBA
01/2023
1Complement System Proteins (Complement)IBA
01/2022
1PolymersIBA
12/2020
1Biocompatible Materials (Biomaterials)IBA
12/2020
1AntibodiesIBA
12/2020
1daratumumabIBA
12/2020
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2020
1Metformin (Glucophage)FDA LinkGeneric
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1HexokinaseIBA
01/2018
1Protein Isoforms (Isoforms)IBA
01/2018
1pegfilgrastim (Neulasta)FDA Link
01/2018
1Cyclin BIBA
02/2017
1VorinostatFDA Link
02/2016
1entinostat (MS 275)IBA
05/2015
1NucleotidesIBA
06/2014
1fludarabineIBA
06/2014
1temsirolimusFDA Link
06/2014
1Bendamustine HydrochlorideFDA Link
06/2014
1GemcitabineFDA Link
06/2014
1Cisplatin (Platino)FDA LinkGeneric
06/2014
1Cytarabine (Cytosar-U)FDA LinkGeneric
06/2014
1Deoxycytidine KinaseIBA
06/2014
1NucleosidesIBA
06/2014
1CladribineFDA LinkGeneric
06/2014
1MLN2238IBA
11/2013
1Therapeutic UsesIBA
06/2011
1obatoclaxIBA
06/2011

Therapy/Procedure

11Drug Therapy (Chemotherapy)
11/2023 - 06/2011
8Therapeutics
01/2023 - 12/2010
1Immunotherapy
01/2020
1Investigational Therapies (Experimental Therapy)
06/2014